Jamie Boland died in June last year aged 38 after battling ketamine addiction and now his parents have called for the drug to ...

The United States and its biggest trading partners were hurtling Sunday into a new era of protectionism as Canada, Mexico and ...

The U.S. Food and Drug Administration (FDA) created a major media stir last week when it announced the approval of suzetrigine (brand name Journavx), a unique new non-opioid, non-addictive drug for ...

City conceded a goal inside two minutes and was overwhelmed in the second half in a 5-1 loss at Arsenal, which trimmed the ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

President Donald Trump said Sunday that Americans could feel “some pain” from the emerging trade war triggered by his tariffs ...

The Oscar-nominated lead of the movie "Emilia Pérez" is apologizing for her old social media posts that denigrated Islam and that called George Floyd "a drug addict." ...

A new drug approved Thursday by the FDA offers pain management but is not addictive. Unlike opioids, it treats pain signals ...

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

It's the first new pharmaceutical approach to treating pain in over 20 years, designed to eliminate risks of addiction and overdose associated with opioids.

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.